The 20 Best Hepatitis C Doctors near Baltimore, MD

Dr. Oluwaseun O. Falade-Nwulia is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include infectious disease. Dr. Falade-Nwulia earned her M.B.B.S. from the University of Ibadan Medical School College of Medicine. She completed her residency at Johns Hopkins Bayview Medical Center. She performed fellowships in infectious diseases at Johns Hopkins and a fellowship in critical care medicine at the National Institutes of Health. Dr. Falade is rated as an Elite provider by MediFind in the treatment of Hepatitis C. Her top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Sepsis.

Dr. Moon’s area of clinical expertise is infectious diseases. She earned her M.D. at the Ross University School of Medicine. Dr. Moon completed her residency at Allegheny General Hospital and performed a fellowship in infectious diseases at Penn State Milton S. Hershey Medical Center. Dr. Moon is rated as a Distinguished provider by MediFind in the treatment of Hepatitis C. Her top areas of expertise are Hepatitis C, Hepatitis, Osteomyelitis, and HIV/AIDS.

Dr. Ashwin Balagopal is an assistant professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is infectious diseases. After receiving his medical degree from Mount Sinai School of Medicine, Dr. Balagopal completed his residency in internal medicine at Yale-New Haven Hospital. He performed his fellowship in infectious diseases at the Johns Hopkins University School of Medicine. Dr. Balagopal's research interests include microbial translocation and Kupffer cells in HIV-HCV coinfection and in situ liver studies of HIV-HCV pathogenesis. Dr. Balagopal is rated as a Distinguished provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis, Hepatitis C, HIV/AIDS, and Hepatitis B.

Stuart C. Ray, MD, FACP, FIDSA is a Professor in the Division of Infectious Diseases within the Department of Medicine, with a research appointment in Oncology. He is a virologist and clinical investigator in the Viral Immunity & Pathogenesis Center in the Division of Infectious Diseases. He is a faculty member of the Janeway Firm of the Osler Medical Service, and the graduate programs in Immunology, Pharmacology, and Health Sciences Informatics. He is a member of the Johns Hopkins Medicine AI & Data Trust Council, and Co-Chair of the Research Data Subcouncil. Dr. Ray received his M.D. from Vanderbilt University School of Medicine in 1990. After an internship and residency at Johns Hopkins Hospital, he continued there as an Assistant Chief of Service and fellow in Infectious Diseases. During his fellowship, he studied the immunology and sequence variation of HIV in the laboratory of Dr. Robert Bollinger. During that time, he developed an interest in RNA virus evolution in productive collaborations with Dr. Robert Siliciano. In 1997 Dr. Ray joined the Johns Hopkins faculty, and under the mentorship of Dr. David Thomas shifted his primary research focus to hepatitis C virus (HCV). His laboratory work has focused on the evolution of HCV during acute and chronic infection, developing and applying computational and molecular biology tools to underlying mechanisms including stochastic variation, immune selection, and viral fitness. He continues to care for patients with HIV, HCV, and other infectious diseases. Dr. Ray is rated as a Distinguished provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Severe Acute Respiratory Syndrome (SARS).

Dr. Chloe Thio is a professor of medicine and an associate professor of molecular microbiology and immunology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include hepatitis, HIV/AIDS and infectious disease. Dr. Thio received her B.A. from the University of Pennsylvania. She earned her M.D. from the Yale University School of Medicine. She completed her residency at Hospital of the University of Pennsylvania and her fellowship in infectious diseases at Johns Hopkins. Her research interests include chronic hepatitis B and C and coinfection of viral hepatitis with HIV/AIDS. She has developed a program centered around virology and immunology translational work towards an HBV cure. Dr. Thio is a member of the American College of Physicians, the American Association for the Study of Liver Disease, the American Society of Clinical Investigation, HIVMA and the Infectious Diseases Society of America. Dr. Thio is rated as a Distinguished provider by MediFind in the treatment of Hepatitis C. Her top areas of expertise are Hepatitis, Hepatitis B, Hepatitis C, and HIV/AIDS.

Dr. Bailey received his M.D. and Ph.D. degrees from the Johns Hopkins University School of Medicine through the Medical Scientist Training Program and completed medical residency at the Massachusetts General Hospital. He subsequently completed fellowship training in Infectious Diseases at the Johns Hopkins University School of Medicine before transitioning to a faculty position. His primary clinical interests are management and treatment of HIV and viral hepatitis, including hepatitis c virus. His research interests include the study of human B cells and neutralizing antibody responses against hepatitis C virus (HCV), hepatitis B virus (HBV), SARS-CoV-2, and respiratory syncytial virus (RSV), with the goal of developing improved vaccines against these viruses. Dr. Bailey is rated as a Distinguished provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis C, Hepatitis, COVID-19, and HIV/AIDS.

Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is rated as a Distinguished provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, and Hepatitis B.

Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is rated as an Elite provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B.

Dr. Christine Durand, associate professor of medicine and oncology and member of the Johns Hopkins Kimmel Cancer Center, is involved in clinical and translational research focused on individuals infected with HIV and hepatitis C virus who require cancer and transplant therapies. Her current research efforts include looking at outcomes of hepatitis C treatment after solid organ transplant, the potential use of organs from HIV-infected donors for HIV-infected solid organ transplant candidates, and HIV cure strategies including bone marrow transplantation. Dr. Durand is rated as an Elite provider by MediFind in the treatment of Hepatitis C. Her top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, Tissue Biopsy, and Nephrectomy.

Dr. Andrea L. Cox is a professor of Internal Medicine at the Johns Hopkins University School of Medicine in the Division of Infectious Diseases and is a member of the Johns Hopkins Kimmel Cancer Center. She holds joint appointments in Oncology and at the Johns Hopkins Bloomberg School of Public Health, in Molecular Microbiology and Immunology. She is an internationally recognized leader in studies of immune responses in immunocompetent and immunocompromised patient populations to viral infections and vaccines against them, including SARS-Co-V-2 (the virus that causes COVID-19), HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV). Dr. Cox earned her Ph.D. in chemistry from the University of Virginia, where she characterized peptides that drive T cell responses. She then earned her M.D. and completed internal medicine residency and infectious disease fellowship training at Johns Hopkins. She leads the largest prospective cohort study of acute HCV infection, designed to enable detailed molecular analysis of HCV transmission, host immune responses, and virus sequence evolution. She co-led the first prophylactic HCV vaccine trial in individuals at risk of HCV infection. She leads a multidisciplinary international team investigating HCV-specific immune responses to improve vaccine development against HCV, is the lead immunologist on a clinical trial of HBV vaccines in people living with HIV, and co-leads a large team investigating immune responses to COVID-19 infection and vaccines. In addition to her research on viral infections and vaccines, Dr. Cox is actively involved in clinical care of patients with HCV, HIV, and HBV infections. Dr. Cox serves as the director of the Medical Scientist Training Program. A teacher, advisor, and mentor of physician-scientists and scientists, Dr. Cox mentors Ph.D. students in the Johns Hopkins Cellular and Molecular Medicine, Molecular Microbiology and Immunology, and the Immunology graduate training programs. Dr. Cox is rated as an Elite provider by MediFind in the treatment of Hepatitis C. Her top areas of expertise are Hepatitis C, Hepatitis, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

Paul Thuluvath is a Gastroenterologist in Lutherville, Maryland. Dr. Thuluvath is rated as an Elite provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Liver Failure, Hepatitis, Hepatitis C, Liver Transplant, and Endoscopy.

Dr. Gurakar joined Johns Hopkins from the Nazih Zuhdi Transplantation Institute at the Integris Baptist Medical Center in Oklahoma City, where he was the chief of Hepatology Research and the program director of the Liver Transplantation Medicine/ Hepatology Fellowship. He served at various capacities in the Liver Medicine Section, since its first establishment in 1993. Dr. Gurakar's clinical interests include pre and post-transplant, clinical and endoscopic management of liver diseases and viral hepatitis. His research interests include bioartificial liver dialysis systems and application of total plasma exchange in the treatment of liver disorders. Dr. Gurakar is rated as a Distinguished provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis, Liver Failure, Alcoholic Cirrhosis, Liver Transplant, and Kidney Transplant.

Dr. Gail Berkenblit is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include infectious disease and internal medicine. Dr. Berkenblit serves as the associate program director for ambulatory education of the Osler Medicine Housestaff Training Program. She received her undergraduate degree from MIT in 1990. She began her medical training in the Health Sciences and Technology joint program between Harvard and MIT. She completed her Ph.D. in the division of cell and developmental biology at Harvard, discovering the role of homeobox genes in uterine development and embryo implantation. She completed medical school and residency training in internal medicine at Johns Hopkins. Her research interests include the design and evaluation of an internet-based curriculum and improving resident training in HIV outpatient care. Dr. Berkenblit serves as chair of the Society of General Internal Medicine’s AIDS Task Force. She was recognized with the David E. Rogers Junior Faculty Education Award by the Society of General Internal Medicine in 2011. Dr. Berkenblit is rated as an Advanced provider by MediFind in the treatment of Hepatitis C. Her top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Myelitis.

Dr. Ma is an assistant professor of medicine at the Johns Hopkins University School of Medicine. She received her medical degree from the University of Michigan Medical School and completed her internal medicine residency at the University of Pennsylvania. Following her residency, she performed a fellowship in transplant hepatology at the Johns Hopkins University School of Medicine. Dr. Ma specializes in liver disorders including alcoholic liver disease, viral hepatitis, non-alcoholic fatty liver disease, metabolic liver disorders, as well as the care of patients after liver transplant. Dr. Ma also has interests in medical education and currently serves as the Associate Program Director of the Gastroenterology Fellowship. Dr. Ma is rated as an Advanced provider by MediFind in the treatment of Hepatitis C. Her top areas of expertise are Hepatitis, Cirrhosis, Hepatitis C, Endoscopy, and Gastrectomy.

Dr. Gregory M. Lucas is an associate professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include HIV/AIDS and infectious disease. Dr. Lucas received his undergraduate degree from the University of Notre Dame. He earned his M.D. from Duke University School of Medicine and his Ph.D. from Johns Hopkins. He completed his residency and performed a fellowship in infectious diseases at Johns Hopkins. He serves on the faculties of the Center for AIDS Research, where he is co-director of the Substance Use Scientific Working Group; the Center for Substance Abuse Treatment and Research; the Center for Adolescent Health; and the Heart and Vascular Institute. Dr. Lucas is rated as an Advanced provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are HIV/AIDS, Hepatitis C, Myelitis, and AIDS Dysmorphic Syndrome.

Dr. Benjamin Philosophe is the surgical director of the Johns Hopkins Comprehensive Transplant Center. He also serves as the lead transplant surgeon at Sibley Memorial Hospital’s Hepatology Multidisciplinary Center. Dr. Philosophe was the first physician to perform robotic total right and total left hepatic resections in the state of Maryland. He has expanded the application of minimally invasive surgical approaches to other hepatobiliary diseases and has improved outcomes and reduced effects of surgery on these patients. Dr. Philosophe practices out of The Johns Hopkins Hospital in Baltimore, Md., as well as Johns Hopkins Community Physician locations in Bethesda, Md. and Lutherville, Md. He is also affiliated with Suburban Hospital and Johns Hopkins Howard County Medical Center. Dr. Philosophe has a wide range of expertise, including cirrhosis; hepatic surgery, hepatitis, hepatobiliary conditions and surgeries; biliary tract surgery and hepatopancreatobiliary surgery; laparoscopic surgeries; vascular surgery; and robotic surgeries. He also has an expertise in various kinds of transplant surgeries, such as kidney, live donor liver, liver and pancreas, as well as various kinds of cancer, such as bile duct, gallbladder, hepatocellular, liver and pancreatic. Dr. Philosophe earned his medical degree from Boston University School of Medicine. He completed a residency in general surgery at Barnes-Jewish Hospital, followed by a liver transplantation fellowship at the University of Toronto. Dr. Philosophe also completed a transplant surgery fellowship at the University of Maryland, where he went on to work as a professor of surgery and the head of liver transplantation and hepatobiliary surgery. Dr. Philosophe is a member of the American Board of Surgery, the Clinical Robotic Surgery Association, the American Society of Transplant Surgeons, the Transplantation Society and the International Liver Transplantation Society. He has earned a Super Doctors Award in general surgery from the Washington Post Magazine, as well as a Top Doctor Award for hepatobiliary surgery and transplant specialists from Baltimore Magazine. Dr. Philosophe has also been repeatedly named one of America’s Top Doctors and one of America’s Top Doctors for Cancer by Castle Connolly. Dr. Philosophe has contributed to numerous publications and presentations. His research interests include uncovering the mechanisms that contribute to transplant rejection and determining characteristics that can be used to better predict donor organ function. He has completed pioneering work in developing a scoring system called the Maryland Aggregate Pathology Index (MAPI), which is used by transplant surgeons worldwide to assess the likelihood of a deceased donor’s kidney function after transplantation. MAPI has increased the utilization of donor kidneys and saved many lives. Dr. Philosophe is rated as an Advanced provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis, Liver Failure, End-Stage Renal Disease (ESRD), Liver Transplant, and Kidney Transplant.

Dr. Stephen Berry is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include HIV medicine and general infectious diseases. He serves as the Vice Chair for Quality, Safety and Service in the Department of Medicine. Dr. Berry graduated summa cum laude from Emory University and joined the Peace Corps to work as a science teacher in Malawi. He then completed medical school, an internal medicine residency and a chief resident year at the University of Pennsylvania School of Medicine. He performed a fellowship in infectious diseases at Johns Hopkins as well as a Ph.D. from the graduate training program in clinical investigation. Dr. Berry joined the Johns Hopkins faculty in 2010. Dr. Berry’s research focuses on health services utilization and quality and secondary HIV prevention among persons living with HIV. He also focuses on the role of quality metrics in the US healthcare system's transition to value based care. Dr. Berry is rated as an Advanced provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Myelitis, AIDS Dysmorphic Syndrome, AIDS Dementia Complex, and HIV/AIDS.

Dr. Wikrom Karnsakul is an associate professor of pediatrics at the Johns Hopkins University School of Medicine. His clinical interests are in the care of pediatric liver diseases, and general gastrointestinal diseases. Dr. Karnsakul received his medical degree in 1992 from Faculty of Medicine, Siriraj Medical Center, Mahidol University School of Medicine in Bangkok, Thailand. He completed his residency in pediatrics at Advocate Hope Children's Hospital in 1998 and did a fellowship in pediatric gastroenterology, hepatology and nutrition at Texas Children's Hospital, Baylor College of Medicine in Houston, Texas. He completed his postdoctoral research training at USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine. He joined the faculty at Johns Hopkins in 2008. His research interests center on the understanding and treatment of chronic liver disease, ascites, cholestasis, viral hepatitis especially hepatitis C and hepatitis E, and Cystic Fibrosis Related Liver Disease. Dr. Karnsakul is also involved in NIH-funded multicenter research studies including the Cholestatic Liver Disease Consortium and Cystic Fibrosis Related Liver Disease Project. Dr. Karnsakul is currently a Fellow of the American Association for the Study of Liver Diseases (FAASLD). Dr. Karnsakul is rated as an Advanced provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Alagille Syndrome, Cholestasis, Hepatitis E, Liver Transplant, and Endoscopy.

Dr. Richard Moore is recognized for mentorship of medical students, residents, fellows, and junior faculty in HIV/AIDS Research. Winner of the David M. Levine Mentorship Awards in the General Internal Medicine Department, he is an expert in pharmacoepidemiology, clinical epidemiology, and health services research. Now serving as the Director of the Moore Clinic for HIV Care, which began in 1984, he has influenced the careers of young scholars not only in General Internal Medicine, but also in the Infectious Disease Division. His colleagues and mentees praise him for his accessibility, his patience, his scientific candor, his instinct for compelling research, his insight, and his abilities as a teacher and editor. Dr. Moore has authored 129 original manuscripts, 24 chapters, reviews and letters. For his medical degree he attended Vanderbilt University School of Medicine where he also completed his Internship and Residency in the Department of Medicine. A fellowship, completed at Johns Hopkins University, Department of Medicine, Division of Internal Medicine, was followed by a Masters of Health Sciences at the Johns Hopkins University, Bloomberg School of Public Health, Department of Epidemiology. Dr. Moore is rated as a Distinguished provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are HIV/AIDS, Sepsis, Hepatitis C, Hepatitis, and Gastrostomy.

Dr. Risha Irvin is an associate professor at Johns Hopkins School of Medicine in the Division of Infectious Diseases where she focuses her clinical care, research, and community engagement projects on improving the health of vulnerable populations impacted by HIV and/or hepatitis C virus (HCV). Dr. Irvin obtained her bachelor’s degree in biology from Spelman College and her medical degree and master’s in public health from Harvard Medical School/Harvard School of Public Health. Dr. Irvin completed her residency training in internal medicine at the University of California San Francisco. Dr. Irvin is rated as a Distinguished provider by MediFind in the treatment of Hepatitis C. Her top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Jaundice.